Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies

Journal of Neurology Neurosurgery and Psychiatry

Volumn 60, Issue 4, 1996, Pages 388-392

  Uchuya, M ^a   Graus, F ^b   Vega, F ^a   Rene R ^c   Delattre, J Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HOSPITAL CLÍNIC   (Spain)

^c Hospitalet del Llobregat   (Spain)

Author keywords

Antineuronal autoantibodies; Immunoglobulin treatment; Paraneoplastic neurological syndromes; Rankin scale

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CYANOSIS; DISEASE COURSE; FEMALE; FEVER; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALAISE; MALE; PARANEOPLASTIC SYNDROME; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SENSORY NEUROPATHY; TIME; TREATMENT OUTCOME;

EID: 0029944378     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.60.4.388     Document Type: Article

References (24)

1. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988; 38:1391-8.
2. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. A clinical study of 71 patients. Medicine 1992; 71:59-72.
3. Chabriat H, Chen QM, Poisson M, Delattre JY. Dégénérescence cérébelleuse paranéoplasique. Rev Neurol (Paris) 1994;150:105-14.
4. Peterson K, Rosemblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992;42:1931-7.
5. Graus F, Vega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992;42:536-40.
6. Cook D, Dalakas M, Galdi A, Biondi D, Porter H. High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 1990;40:212-4.
7. Faed JM, Day B, Pollock M, Taylor PK, Nukada H, Hammond-Tooke GD. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Neurology 1989;39:422-5.
8. Roifman CM, Schaffer FM, Wachsmuth SE, Murphy G, Gelfand EW. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA 1987;258:513-5.
9. Vermeulen M, Van der Meché FGA, Speelman JD, Weber A, Busch HFM. Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci 1985;70:317-26.
10. Van Doom PA, Brand A, Strengers PFW, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating neuropathy: a double-blind, placebo-controlled, crossover study. Neurology 1990;40:209-12.
11. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 1994;44:2241-6.
12. Vermeulen M, Van Doom PA, Brand A, Strengers PFW, Jennekens FGI, Busch HFM. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993; 56:36-9.
13. Soueidan SA, Dalakas MC. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Pediatr Res 1993;33(suppl):S95-S100.
14. Delattre JY, Davila L, Vega F, Poisson M. Auto-Immunité et syndromes neurologiques paranéoplasiques. Rev Neurol (Paris) 1991;147:549-56.
15. Twijnstra A, Verschuuren J, Byrne TN, De Baets M, Posner J, Dalmau J. Prolonged or remitting AnU-Hu-associated paraneoplastic sensory neuronopathy (PSN) and encephalomyelitis (PEM). Neurology 1995;45 (suppl 4):A321.
16. Graus F, Bonaventura I, Uchuya M, et al. Indolent anti-Hu-associated parancoplastic sensory neuropathy. Neurology 1994;44:2258-61.
17. Vega F, Graus F, Chen QM, Poisson M, Schuller E, Delattre JY. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation. Neurology 1994;44:2145-7.
18. Amato AA, Comman EW, Kissel JT. Treatment of stiffman syndrome with intravenous immunoglobulin. Neurology 1994;44:1652-4.
19. Counsell CE, McLeod M, Grant R. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology 1994;44:1184-5.
20. Moll JWB, Henzen-Logmans SC, Van der Meche FGA, Vecht Ch J. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 1993;56:112-5.
21. Dietrich G, Kaveri SV, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992;62:S73-S81.
22. Cornblath DR, Chaudry V, Griffin JW. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 1991;30: 104-6.
23. Gajdos P. Intravenous immune globulin in myasthenia gravis. Clin Exp Immunol 1994;97(suppl 1):49-51.
24. Takano H, Tanaka M, Koike R, Nagai H, Arakawa M, Tsuji S. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage gated calcium channel antibody. Muscle Nerve 1994;17:1073-5.